GlassScriptPhysician profile
David Ellis Conston
NPI 1497773733
$1,034.96
in general payments reported to CMS, 2019-2025
23 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.02 · 2020: $32.71 · 2021: $13.93 · 2022: $122 · 2023: $261 · 2024: $391 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $141.27 | 2023-2025 | |
| Rigel Pharmaceuticals, INC. | $126.41 | 2022-2024 | Rezlidhia, Tavalisse |
| Janssen Biotech, INC. | $118.32 | 2023-2024 | Darzalex, Tecvayli, Talvey |
| Astrazeneca Pharmaceuticals LP | $104.17 | 2023-2025 | Enhertu, Calquence |
| Incyte Corporation | $94.59 | 2022-2025 | Jakafi |
| Pfizer INC. | $54.24 | 2024 | |
| Ge Healthcare | $48.38 | 2025 | |
| Deciphera Pharmaceuticals INC. | $40.50 | 2024-2025 | Qinlock, Romvimza |
| Coherus Oncology, INC. | $34.63 | 2021-2024 | |
| Intuitive Surgical, INC. | $34.56 | 2024 | |
| Pharmaessentia USA Corporation | $32.82 | 2024 | Besremi |
| Seagen INC. | $23.10 | 2022 | |
| Hologic Sales and Service, LLC | $20.96 | 2024 | Brevera Breast Biopsy System, 3dquorum |
| Merck Sharp & Dohme LLC | $20.79 | 2020 | |
| Amgen INC. | $19.38 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blueprint Medicines Corporation | $19.08 | 2024 | Ayvakit |
| Lilly USA, LLC | $18.86 | 2023 | Jaypirca, Retevmo |
| Emd Serono, INC. | $17.96 | 2024 | |
| Daiichi Sankyo INC. | $14.49 | 2025 | Enhertu |
| Karyopharm Therapeutics INC. | $13.85 | 2024 | Xpovio |
| Glaxosmithkline, LLC. | $13.02 | 2019 | |
| Siemens Medical Solutions USA, INC. | $11.92 | 2020 | |
| Novartis Pharmaceuticals Corporation | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Conston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.